Last €75.48 EUR
Change Today +0.71 / 0.95%
Volume 2.1M
SAN On Other Exchanges
Symbol
Exchange
EN Paris
EN Paris
New York
OTC US
BrsaItaliana
Mexico
EN Paris
Frankfurt
Frankfurt
NASDAQ GM
As of 11:39 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David-Alexandre Gros

Chief Strategy Officer and Executive Vice President, Sanofi
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

41--

Background*

Dr. David-Alexandre Gros has been the Chief Strategy Officer at Sanofi since September 1, 2011 and serves as its Executive Vice President. Dr. Gros covers all Group business development and acquisition activities as well as strategic planning, economic evaluation of projects, strategic intelligence, and alliance management. Dr. Gros was an advisor to pharmaceutical, biotechnology and diagnostic companies as a Principal and founding member of the Healthcare Investment ...

Read Full Background

Corporate Headquarters*

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA 2002
Harvard Business School
BA 1995
Dartmouth College
MD 1999
Johns Hopkins School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €75.48 EUR +0.71

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Lars Rebien Sørensen Chief Executive Officer and Member of the Senior Management Board
Novo Nordisk A/S
kr11.3M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.